ABBOTT LABORATORIES — Director's Dealing 2014

Jul 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-07-01

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-01	Common shares without par value	A	6077	—	Acquired	35556	Direct
2014-07-01	Common shares without par value	F	1840	$40.90	Disposed	33716	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	2314	Indirect

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of July 1, 2014.